Fruit of the close collaboration between the Geneva University Hospitals (HUG) and the Swiss Institute of Bioinformatics (SIB), Oncobench® is a new genomic analysis platform in the field of oncology. It was designed to analyze tumor data in clinical practice of a total of 50 genes for dozens of patients at each sequencing, in order to collect 500 million DNA data per patient. The genomic analysis allows for a faster and more accurate diagnosis of cancer.

The Oncobench® platform is intended to be shared with other hospitals in the near future, as part of a nationwide implementation of top-quality clinical bioinformatics tools. This initiative is aimed at fostering the development of personalized medicine, the Geneva University Hospitals said in a press release.